Loading...
ARPA-H-SOL-26-147
Response Deadline
May 23, 2026, 3:59 AM(EDT)36 days
Eligibility
Contract Type
Solicitation
Amendment 1: Added Appendixes A - I separately under the Attachments section.
The Advanced Research Projects Agency for Health (ARPA-H) is posting this Innovative Solutions Opening (ISO) in support of the One Comprehensive Universal Radiotherapy for Everyone (1-CURE) Program. ARPA-H anticipates that multiple Other Transaction (OT) Agreements will result from this announcement.
Interested parties are invited to review the attached 1-CURE_ISO_ARPA-H-SOL-26-147 and its Appendices A - C.
Additionally, proposers are encouraged to review the separate Special Notice, ARPA-H-SN-26-152, for information regarding the 1-CURE Proposers’ Day. Special Notice, ARPA-H-SN-26-152, is an independent announcement and is not attached to this ISO announcement.
All questions submitted to the ISO will be compiled and addressed. All answers will be posted to the 1-CURE Frequently Asked Questions (FAQ) page. Potential proposers are encouraged to monitor the FAQs page regularly for the latest information and updates: https://arpa-h.gov/explore-funding/programs/1-cure/faqs
The 1-CURE Team
DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTES OF HEALTH
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
1301 K Street NW
Suite 1200 West
Washington, DC, 20005
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT